LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Vivani Medical

Closed

1.14 0.88

Overview

Share price change

24h

Current

Min

1.12

Max

1.16

Key metrics

By Trading Economics

Employees

37

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+247.83% upside

Dividends

By Dow Jones

Next Earnings

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

-1.4M

62M

Previous open

0.26

Previous close

1.14

Vivani Medical Chart

Past performance is not a reliable indicator of future results.

Related News

2 Sept 2025, 23:07 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 Sept 2025, 22:10 UTC

Major Market Movers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 Sept 2025, 21:47 UTC

Earnings

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 Sept 2025, 16:52 UTC

Major Market Movers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 Sept 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 Sept 2025, 21:40 UTC

Acquisitions, Mergers, Takeovers

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 Sept 2025, 21:07 UTC

Earnings

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 Sept 2025, 21:07 UTC

Earnings

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 Sept 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Rev $17.35B >ATD.T

2 Sept 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 Sept 2025, 21:05 UTC

Earnings

Couche-Tard 1Q EPS 82c >ATD.T

2 Sept 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Net $782.5M >ATD.T

2 Sept 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2 Sept 2025, 20:53 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 Sept 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 Sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 Sept 2025, 20:27 UTC

Earnings

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 Sept 2025, 20:24 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 Sept 2025, 20:18 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 Sept 2025, 20:17 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 Sept 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 Sept 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 Sept 2025, 20:15 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 Sept 2025, 19:55 UTC

Earnings

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 Sept 2025, 19:50 UTC

Acquisitions, Mergers, Takeovers

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 Sept 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 Sept 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 Sept 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2 Sept 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 Sept 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Comparison

Price change

Vivani Medical Forecast

Price Target

By TipRanks

247.83% upside

12 Months Forecast

Average 4 USD  247.83%

High 4 USD

Low 4 USD

Based on 2 Wall Street analysts offering 12 month price targets forVivani Medical - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Financials

$

About Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.